Recent evidence obtained on a transgenic mouse with prostate-specific conditional expression of SPOP-F133V—the most frequent mutation observed in PCa—indicates that SPOP mutation alone is insufficient to drive tumorigenesis in the mouse prostate. This evidence concerns the gene SPOP and posterior cortical atrophy.